JavaScript is disabled for your browser. Some features of this site may not work without it.
Estadísticas
Número total de visitas
| Vistas | |
|---|---|
| Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 174 |
Visitas al mes
| enero 2025 | febrero 2025 | marzo 2025 | abril 2025 | mayo 2025 | junio 2025 | julio 2025 | |
|---|---|---|---|---|---|---|---|
| Long-Term Efficacy and Safety of Biosimilar CT-P10 Versus Innovator Rituximab in Rheumatoid Arthritis: 48-Week Results from a Randomized Phase III Trial | 5 | 9 | 9 | 14 | 3 | 4 | 0 |
Países con más visualizaciones
| Vistas |
|---|
Ciudades con más visualizaciones
| Vistas |
|---|
